- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Refractory neuroblastoma
Total 9409 results
-
SCRI Development Innovations, LLCBristol-Myers SquibbCompleted
-
University of ArkansasCompleted
-
SCRI Development Innovations, LLCMillennium Pharmaceuticals, Inc.; Aventis PharmaceuticalsCompleted
-
AGO Study GroupCompletedOvarian Cancer | Peritoneal Cancer | Cancer of the Fallopian TubeGermany
-
Wyeth is now a wholly owned subsidiary of PfizerCompletedSpondylarthropathies, EnthesitisFrance, Germany, Netherlands
-
Cooperative Study Group A for HematologyUnknownThrombocytopeniaKorea, Republic of
-
University of California, IrvineCompletedOveractive BladderUnited States
-
TakedaCompleted
-
University of ArkansasCompletedMultiple MyelomaUnited States
-
University of ArkansasCelgene CorporationCompleted
-
University of ArkansasCompleted
-
SCRI Development Innovations, LLCMillennium Pharmaceuticals, Inc.CompletedMultiple MyelomaUnited States
-
University of ZurichCompletedOveractive Bladder SyndromeSwitzerland
-
MedImmune LLCCompletedLymphoma | LeukemiaUnited States
-
MedImmune LLCCompleted
-
European Organisation for Research and Treatment...CompletedMyelodysplastic Syndromes | LeukemiaFrance, Belgium, Portugal
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedLeukemiaUnited States
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedLymphoma | LeukemiaUnited States
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedMultiple Myeloma and Plasma Cell NeoplasmUnited States
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedMyelodysplastic Syndromes | LeukemiaUnited States
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedLymphoma | Myelodysplastic Syndromes | Leukemia | Multiple Myeloma and Plasma Cell Neoplasm | Myelodysplastic/Myeloproliferative DiseasesUnited States
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedMyelodysplastic Syndromes | Leukemia | Myelodysplastic/Myeloproliferative DiseasesUnited States
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedMyelodysplastic Syndromes | Leukemia | Myelodysplastic/Myeloproliferative DiseasesUnited States
-
American College of Radiology Imaging NetworkNational Cancer Institute (NCI)UnknownSarcoma | Lymphoma | NeuroblastomaUnited States, Canada
-
Kaplan Medical CenterGilead SciencesUnknownChronic Lymphocytic LeukemiaIsrael
-
Florida Academic Dermatology CentersCelgene CorporationUnknownCutaneous T Cell LymphomaUnited States
-
European Organisation for Research and Treatment...UnknownMyelodysplastic Syndromes | LeukemiaSwitzerland, Netherlands, France, Belgium, Germany, Sweden, Croatia, Czech Republic, Italy
-
Fudan UniversitySuspended
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Vanak Eye Surgery CenterUnknownRefractory GlaucomaIran, Islamic Republic of
-
National Taiwan University HospitalCompleted
-
Hamilton Health Sciences CorporationHoffmann-La Roche; McMaster University; Canadian Apheresis GroupUnknownThrombotic Thrombocytopenic Purpura | Hemolytic Uremic SyndromeCanada
-
University Health Network, TorontoUnknown
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedLymphoma | Myelodysplastic Syndromes | Leukemia | Testicular Germ Cell Tumor | Breast Cancer | Chronic Myeloproliferative Disorders | Ovarian Cancer | Gestational Trophoblastic Tumor | Neuroblastoma | Multiple Myeloma and Plasma Cell Neoplasm | Myelodysplastic/Myeloproliferative Diseases | Graft Versus Host...United States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedLymphoma | Unspecified Childhood Solid Tumor, Protocol Specific | Unspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedLymphoma | Myelodysplastic Syndromes | Leukemia | Chronic Myeloproliferative Disorders | Multiple Myeloma and Plasma Cell Neoplasm | Myelodysplastic/Myeloproliferative Diseases | Graft Versus Host DiseaseUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedMyelodysplastic Syndromes | LeukemiaUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...National Cancer Institute (NCI)CompletedLeukemia | Chronic Myeloproliferative Disorders | Myelodysplastic/Myeloproliferative DiseasesUnited States
-
Cellectar, IncCompletedSolid TumorsUnited States
-
Janssen-Ortho Inc., CanadaOntario Clinical Oncology Group (OCOG)Completed
-
Johnson & Johnson Pharmaceutical Research & Development...Janssen-Cilag Ltd.Completed
-
Bristol-Myers SquibbWithdrawnLymphoma, Large-CellUnited States, France
-
Johnson & Johnson Pharmaceutical Research & Development...Janssen Pharmaceutica N.V., BelgiumCompletedPharmacokinetics | Advanced Malignancies | Solid Malignancies | Protein Kinase Inhibitors | Maximum Tolerated Dose | Antineoplastic Protocols | Clinical Trial, Phase 1
-
Bristol-Myers SquibbWithdrawnChronic Lymphocytic Leukemia or Mantle Cell Lymphoma.
-
European Organisation for Research and Treatment...UnknownMyelodysplastic Syndromes | Leukemia | Myelodysplastic/Myeloproliferative NeoplasmsBelgium, Netherlands, Germany, Italy, United Kingdom, Austria, Czech Republic, Croatia, Turkey, Switzerland
-
Novartis PharmaceuticalsTerminatedHormone Refractory Prostate Cancer DiseaseUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedLymphoma | Myelodysplastic Syndromes | Leukemia | Chronic Myeloproliferative Disorders | Small Intestine Cancer | Multiple Myeloma and Plasma Cell Neoplasm | Precancerous/Nonmalignant ConditionUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)Completed
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedMyelodysplastic Syndromes | LeukemiaUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedMyelodysplastic Syndromes | LeukemiaUnited States